scholarly journals Using GH-Method: Math-Physical Medicine to Investigate Different Contribution Margins of Fasting Plasma Glucose vs. Postprandial Plasma Glucose on HbA1C

This paper displays results of the contribution margin calculation of fasting plasma glucose (FPG) vs. postprandial plasma glucose (PPG) on HbA1C. The dataset is provided by the author, who uses his own type 2 diabetes metabolic conditions control, as a case study via the “math-physical medicine” approach of a nontraditional methodology in medical research.

2020 ◽  
Vol 5 (2) ◽  

This paper summarizes tips and guidelines of optimized combination of food and exercise for type 2 diabetes (T2D) patients to control their glucoses. The dataset is provided by the author, who uses his own type 2 diabetes metabolic conditions control, as a case study via the “math-physical medicine” approach of a non-traditional methodology in medical research.


2020 ◽  
Vol 5 (3) ◽  

This paper is based on big data collected from a period of 1,420daysfrom 6/1/2015 to 4/21/2019 with a total of 4,260 data, including highest ambient temperature (weather) of each day in degree Fahrenheit (°F), fasting plasma glucose (FPG) and postprandial plasma glucose (PPG) in mg/dL. The dataset is provided by the author, who uses his own type 2 diabetes metabolic conditions control, as a case study via the “math-physical medicine” approach of a non-traditional methodology in medical research.


2020 ◽  
pp. 1-4
Author(s):  
Gerald C. Hsu

In this paper, the author describes his hypothesis on the probable partial self-recovery of some insulin regeneration capability of pancreatic beta cells on a Type 2 Diabetes (T2D) patient via his collected data of both Postprandial Plasma Glucose (PPG) and Fasting Plasma Glucose (FPG) during the period of 1/1/2014 to 11/23/2019.


This paper describes the accuracy of two different methods of postprandial plasma glucose (PPG) prediction in comparison with the actual measured PPG by using the finger-piercing and test-strip (Finger) method. The dataset is provided by the author, who uses his own type 2 diabetes metabolic conditions control, as a case study via the “math-physical medicine” approach of a non-traditional methodology in medical research.


2020 ◽  
Vol 5 (3) ◽  

Introduction The data-set is provided by the author, who uses his own type 2 diabetes (T2D) metabolic conditions control, as a case study via the “math-physical medicine” approach of a non-traditional methodology in medical research.


2020 ◽  
Vol 4 (2) ◽  

In this paper, the author describes his hypothesis on the probable self-recovery of partial insulin regeneration capacity of pancreatic beta cells of a type 2 diabetes (T2D) patient via his collected data of both postprandial plasma glucose (Finger PPG and Sensor extended baseline PPG) and fasting plasma glucose (Finger FPG) during the period of 1/1/2014 to 4/5/2020.


2020 ◽  
Vol 4 (2) ◽  

In this paper, the author describes his hypothesis on the probable self-recovery of partial insulin regeneration capacity of pancreatic beta cells of a type 2 diabetes (T2D) patient via his collected data of both postprandial plasma glucose (Finger PPG and Sensor extended baseline PPG) and fasting plasma glucose (Finger FPG) during the period of 1/1/2014 to 4/5/2020.


2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Mengyi Li ◽  
Xuemin Huang ◽  
Hui Ye ◽  
Yao Chen ◽  
Jing Yu ◽  
...  

Aims. To evaluate the efficacy and safety of mulberry twig alkaloid (SZ-A) tablet compared with acarbose in patients with type 2 diabetes.Methods. This clinical trial enrolled 38 patients who were randomized into two groups (SZ-A: 23; acarbose: 15) and were treated for 24 weeks. Patients and clinical trial staffs were masked to treatment assignment throughout the study. The primary outcome measures were glycated hemoglobin (HbA1c) and 1-hour and 2-hour postprandial and fasting plasma glucose levels from baseline to the end of treatment. Analysis included all patients who completed this study.Results. By the end of this study, HbA1c level in SZ-A group was decreased from baseline significantly (P<0.001). No significant difference was found when compared with acarbose group (P=0.652). Similarly, 1-hour and 2-hour postprandial plasma glucose levels in SZ-A group were decreased from baseline statistically (P<0.05), without any significant differences compared with acarbose group (P=0.748and 0.558, resp.). The fasting plasma glucose levels were not significantly changed in both groups. One of 23 patients in SZ-A group (4.76%) and 5 of 15 patients in acarbose group (33.33%) suffered from gastrointestinal adverse events.Conclusions. Compared with acarbose, SZ-A tablet was effective and safe in glycemic control in patients with type 2 diabetes.


Sign in / Sign up

Export Citation Format

Share Document